Your browser doesn't support javascript.
loading
Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P).
Zhu, Sha; Zhao, Jinge; Nie, Ling; Yin, Wenlian; Zhang, Yaowen; Zhao, Fengnian; Ni, Yuchao; Zhang, Xingming; Wang, Zhipeng; Dai, Jindong; Liu, Zhenhua; Chen, Junru; Zeng, Yuhao; Wang, Zilin; Sun, Guangxi; Liang, Jiayu; Zhao, Xiaochen; Zhu, Xudong; Tao, Ronggui; Yang, Jiyu; He, Ben; Chen, Ni; Shen, Pengfei; Zeng, Hao.
Afiliação
  • Zhu S; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Zhao J; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Nie L; Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Yin W; Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Zhang Y; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Zhao F; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Ni Y; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Zhang X; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Wang Z; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Dai J; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Liu Z; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Chen J; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Zeng Y; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Wang Z; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Sun G; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Liang J; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Zhao X; 3D Medicines Inc., Shanghai, China.
  • Zhu X; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Tao R; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Yang J; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • He B; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Chen N; Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China. chenni1@163.com.
  • Shen P; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China. cdhx510@163.com.
  • Zeng H; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China. kucaizeng@163.com.
BMC Med ; 20(1): 237, 2022 07 22.
Article em En | MEDLINE | ID: mdl-35864546
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Adenocarcinoma / Carcinoma Intraductal não Infiltrante Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: BMC Med Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Adenocarcinoma / Carcinoma Intraductal não Infiltrante Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: BMC Med Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China